1885 WEST 2100 STREET, SALT LAKE CITY, UT
Regains Compliance with Nasdaq Stockholders’ Equity Requirement
Provides Mid-Year 2026 Business Update Highlighting Commercial Execution, Biomaterial Platform Expansion and Strategic Growth Initiatives
Engages Veteran MedTech Executive
News, Securities Holder Rights or Indentures, Material Contracts
Announces Raise of Approximately $5.0 Million of Capital, Including a $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Eric Olson Steps Down as President; Ryan Elmore Appointed President
Signs Supply Agreement to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants
Q2
Q1
FY 2025
Q3
FY 2024
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Amended Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload